Skip to content

Linq II™ LNQ22TK

by Medtronic, Inc.

Linq II LNQ22TK is an implantable cardiac monitor (FDA Class II) made by Medtronic, Inc., cleared under FDA 510(k) K200795 on 3 Jul 2020 and listed in FDA GUDID since 18 Jul 2020 (UDI-DI 00763000162191), active as of 23 Oct 2026. 3 FDA recalls are linked to it.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

2 ongoing

This device is named in the recall

Documents

510(k) K200795

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00763000162191 UDI-DI Date18 Jul 2020ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK200795 Date3 Jul 2020DecidedStatusActive

Official records

From the FDA record

Device description
TOOL KIT LNQ22TK LINQ II USA
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K200795 decided 3 Jul 2020 Active
  • FDA GUDID UDI-DI 00763000162191 listed 18 Jul 2020 Listed

Recalls

3 recalls · 2 ongoing · FDA

    • Ongoing Z-0421-2024 FDA Class II initiated 3 Nov 2023

    It may create the potential for amplified noise and/or overall signal reduction of the ICM, which may interfere with intended recordings of heart rhythms. This noise pattern is different from occasional noise due to device position/migration, patient activity, or external electromagnetic interference.

    • Ongoing Z-2076-2021 FDA Class II initiated 14 May 2021

    Device fail to detect Brady episodes, Pause (Asystole) episodes and PVC's after a ride-through POR reset.

    • Terminated Z-0782-2022 FDA Class II initiated 18 Jan 2022

    Devices may lose functionality due to susceptibility to moisture ingress.

Timeline

5 dated events

  1. Cleared FDA 510(k) K200795
  2. Listed FDA GUDID 00763000162191
  3. Recall initiated FDA recalls Z-2076-2021
  4. Recall initiated FDA recalls Z-0782-2022
  5. Recall initiated FDA recalls Z-0421-2024

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Linq II™
Generic name
Implantable cardiac monitor
Model / reference
LNQ22TK
Primary DI / UDI-DI
00763000162191
510(k) Number
FDA product code
MXD, DSI
GMDN term
Implantable cardiac monitor
Device class
Class II
Regulation number
870.1025
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code MXD (Recorder, event, implantable cardiac, (with arrhythmia detection)).

Other devices from Medtronic, Inc.

See all devices from Medtronic, Inc. →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • Lot / batch number
Other properties (10, all answered No)